| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.2× | −1.7× | |
| Price / Book | 7.9× | 2.0× | |
| Price / Sales | 2.2× | 4.0× | |
| Price / Free cash flow | −7.1× | −1.5× | |
| EV / EBITDA | −6.4× | −1.2× | |
| Earnings yield | −19.2% | −14.3% | |
| Free cash flow yield | −14.0% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,297.00 | +4.57% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.71 | +2.33% | $625.87B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.50 | +2.06% | $509.81B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.50 | +2.86% | $375.64B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.93 | +2.99% | $364.97B | 19.4× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.90 | +1.80% | $281.87B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.67 | +2.88% | $261.59B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.22 | +0.71% | $252.99B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.60 | +2.51% | $235.5B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.89 | +1.84% | $193.3B | 22.3× | 37.5% | +29.9% |
